ArticleArchivum immunologiae et therapiae experimentalis2022

Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.

Maria Siemionow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.